Finance

Lists
Why is XRAY down २.३६%?
Dive Deeper
XRAY:NASDAQ
DENTSPLY SIRONA Inc
US$ ८.२९
-२.३६%
(-०.२०) 1D
US$ ८.३४
+०.६०% (+०.०५०)
After hours
Closed: नोभेम्बर २०, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XRAY...
Open
US$ ८.४५
High
US$ ८.७४
Low
US$ ८.२४
Mkt. cap
१.६४ अरब
Avg. vol.
५०.४३ लाख
Volume
४८.८० लाख
52-wk high
US$ १४.७६
52-wk low
US$ ८.१४
EPS
-US$ ०.६१
Beta
०.८७
Shares outstanding
१९.८२ करोड
No. of employees
१४ हजार
Open
US$ ८.४५
High
US$ ८.७४
Low
US$ ८.२४
Mkt. cap
१.६४ अरब
Avg. vol.
५०.४३ लाख
Volume
४८.८० लाख
52-wk high
US$ १४.७६
52-wk low
US$ ८.१४
EPS
-US$ ०.६१
Beta
०.८७
Shares outstanding
१९.८२ करोड
No. of employees
१४ हजार
News stories
From web sources and news partners
Profile
Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million. As an equipment maker, it designs and manufactures laboratory and specialty products relating to dental supplies. With regard to consumable products, it specializes in anesthetics, plaque and gum disease prevention and tooth polishers. It also designs and constructs artificial teeth. It has also been cited as a key player in the future intra-oral flat panel sensor market. Because of the income disparity between wealthy and developing nations, the variety of products in demand differs from region to region. On August 28, 2022, Dentsply Sirona announced the appointment of Simon D. Campion, formerly Executive Vice President and President of the Interventional segment for BD, as President and Chief Executive Officer and a member of the board. In 2018 a Netherlands-based certification company awarded Dentsply the “Top Employer” certification. Wikipedia
About DENTSPLY SIRONA Inc
CEODaniel T. Scavilla
Employees१४ हजार
Founded२०१६
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 12 analysts giving stock ratings to XRAY in the past 3 months
Hold
Buy
3
Hold
8
Sell
1
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for XRAY in the last 3 months.
Highest
Current US$ ८.२९
US$ १४.०० (+६८.८८%)
Average
US$ १०.८३ (+३०.६४%)
Lowest
US$ ८.०० (-३.५०%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kevin Caliendo
UBS
Buy
Reiterated
US$ १३.००
+५६.८%
11/17/2026
Michael Petusky
Barrington
Buy
Maintained
US$ ११.००
+३२.७%
11/09/2026
Michael Sarcone
Jefferies
Hold
Maintained
US$ १०.००
+२०.६%
11/06/2026
Lilia-Celine (Lily) Lozada
J.P. Morgan
Hold
Maintained
US$ १०.००
+२०.६%
11/06/2026
Allen Lutz
Bank of America Securities
Buy
Reiterated
US$ १४.००
+६८.९%
11/06/2026
Erin Wright
Morgan Stanley
Hold
Reiterated
US$ ११.००
+३२.७%
11/06/2026
Steven Valiquette
Mizuho Securities
Hold
Maintained
US$ ११.००
+३२.७%
11/06/2026
Jeff Johnson
Robert W. Baird
Hold
Maintained
US$ ९.००
+८.६%
11/06/2026
Glen Santangelo
Barclays
Sell
Maintained
US$ ११.००
+३२.७%
11/06/2026
Vik Chopra
BMO Capital
Hold
Maintained
US$ ८.००
-३.५%
11/06/2026
Michael Cherny
Leerink Partners
Hold
Maintained
US$ १०.००
+२०.६%
10/14/2026
Jason Bednar
Piper Sandler
Hold
Reiterated
US$ १२.००
+४४.८%
10/09/2026
Jonathan Block
Stifel Nicolaus
Hold
Maintained
US$ १४.००
+६८.९%
08/07/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
US$ १४.००
+६८.९%
08/07/2026
Brandon Vazquez
William Blair
Hold
Maintained
-
-
08/07/2026
David Saxon
Needham
Hold
Maintained
-
-
08/07/2026
Unknown Analyst
BMO Capital
Hold
Initiated
US$ १२.००
+४४.८%
07/09/2026
Daniel Grosslight
Citi
Sell
Maintained
US$ १०.५०
+२६.७%
05/06/2026
Unknown Analyst
Wells Fargo
Hold
Maintained
US$ १३.००
+५६.८%
02/27/2026
Last report
२०२६ नोभेम्बर ५
Fiscal period
Q3 2026
US$ ०.२९ / US$ ०.३१
-६.२४%miss
Revenue / Est. (USD)
८३.६० करोड / ८६.१७ करोड
-२.९८%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
९६.१० करोड
८८.०० करोड
८९.८० करोड
८३.६० करोड
Cost of goods sold
५१.८० करोड
४५.३० करोड
४०.५० करोड
३९.३० करोड
Cost of revenue
५१.८० करोड
४५.३० करोड
४०.५० करोड
३९.३० करोड
Research and development expenses
४.०० करोड
४.४० करोड
४.५० करोड
४.२० करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३८.६० करोड
३५.३० करोड
३६.५० करोड
३६.४० करोड
Operating expense
४२.६० करोड
३९.७० करोड
४१.०० करोड
४०.६० करोड
Total operating expenses
९४.४० करोड
८५.०० करोड
८१.५० करोड
७९.९० करोड
Operating income
१.७० करोड
३.०० करोड
८.३० करोड
३.७० करोड
Other non operating income
-२०.०० लाख
६०.०० लाख
-
-
EBT including unusual items
-१४.७० करोड
-४.२० करोड
७.२० करोड
२.६० करोड
EBT excluding unusual items
१.२० करोड
२.५० करोड
७.४० करोड
२.७० करोड
Income tax expense
-२०.०० लाख
-३.२० करोड
३.६० करोड
२.९० करोड
Effective tax rate
१.३६%
७६.१९%
५०.००%
१११.५४%
Other operating expenses
-
-
-
-
Net income
-१४.६० करोड
-१.०० करोड
३.७० करोड
-२०.०० लाख
Net profit margin
-१५.१९%
-१.१४%
४.१२%
-०.२४%
Earnings per share
०.२७
०.२७
०.५२
०.२९
Interest and investment income
४०.०० लाख
-
४०.०० लाख
२०.०० लाख
Interest expense
-२.६० करोड
-२.४० करोड
-२.६० करोड
-२.७० करोड
Net interest expenses
-२.२० करोड
-२.४० करोड
-२.२० करोड
-२.५० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
११.०० करोड
१०.९० करोड
१६.८० करोड
११.९० करोड
Gain or loss from assets sale
-
-६०.०० लाख
-
-१०.०० लाख
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू